ATE487700T1 - Trizyklische verbindungen und deren verwendung als glucocorticoidrezeptormodulatoren - Google Patents
Trizyklische verbindungen und deren verwendung als glucocorticoidrezeptormodulatorenInfo
- Publication number
- ATE487700T1 ATE487700T1 AT08702358T AT08702358T ATE487700T1 AT E487700 T1 ATE487700 T1 AT E487700T1 AT 08702358 T AT08702358 T AT 08702358T AT 08702358 T AT08702358 T AT 08702358T AT E487700 T1 ATE487700 T1 AT E487700T1
- Authority
- AT
- Austria
- Prior art keywords
- receptor modulators
- glucocorticoid receptor
- tricyclic compounds
- tricyclic
- compounds
- Prior art date
Links
- 229940117965 Glucocorticoid receptor modulator Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/58—Pyridine rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Psychiatry (AREA)
- Physical Education & Sports Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Transplantation (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US88798107P | 2007-02-02 | 2007-02-02 | |
PCT/IB2008/000249 WO2008093236A1 (en) | 2007-02-02 | 2008-01-28 | Tricyclic compounds and their use as glucocorticoid receptor modulators |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE487700T1 true ATE487700T1 (de) | 2010-11-15 |
Family
ID=39887754
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT08702358T ATE487700T1 (de) | 2007-02-02 | 2008-01-28 | Trizyklische verbindungen und deren verwendung als glucocorticoidrezeptormodulatoren |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP2114888B1 (de) |
JP (1) | JP4579333B2 (de) |
AP (1) | AP2411A (de) |
AT (1) | ATE487700T1 (de) |
AU (1) | AU2008211622B2 (de) |
BR (1) | BRPI0807121A2 (de) |
CA (1) | CA2676907C (de) |
DE (1) | DE602008003405D1 (de) |
DK (1) | DK2114888T3 (de) |
EA (1) | EA016001B1 (de) |
HK (1) | HK1135094A1 (de) |
HR (1) | HRP20100726T1 (de) |
IL (1) | IL200044A (de) |
MX (1) | MX2009008286A (de) |
NZ (1) | NZ578661A (de) |
PL (1) | PL2114888T3 (de) |
SI (1) | SI2114888T1 (de) |
UZ (1) | UZ4378C (de) |
WO (1) | WO2008093236A1 (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2368286T3 (es) * | 2007-02-02 | 2011-11-16 | Pfizer Products Inc. | Compuestos tricíclicos y su uso como moduladores de los receptores de glucocorticoides. |
SI2307375T1 (sl) * | 2008-07-28 | 2015-02-27 | Pfizer Inc. | Fenantrenonove spojine, sestavki in postopki |
MX2013010576A (es) * | 2011-03-15 | 2014-03-12 | Abbvie Inc | Moduladores de receptores de hormonas nucleares. |
WO2013040233A1 (en) * | 2011-09-13 | 2013-03-21 | New York University | Controlling regulatory t cell function |
TW201422590A (zh) | 2012-09-07 | 2014-06-16 | Abbvie Inc | 雜環核激素受體調節劑 |
EP2935284A4 (de) | 2012-12-21 | 2016-04-27 | Abbvie Inc | Heterocyclische nuklearhormonrezeptormodulatoren |
US10494363B2 (en) * | 2015-09-15 | 2019-12-03 | Leo Pharma A/S | Non-steroidal glucocorticoid receptor modulators for local drug delivery |
MX2021006421A (es) | 2018-12-19 | 2021-08-16 | Leo Pharma As | Anilidas de aminoácidos como moduladores de moléculas pequeñas de interleucinas-17 (il-17). |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CZ304203B6 (cs) * | 1999-04-30 | 2014-01-02 | Pfizer Products Inc. | Modulátor glukokortikoidního receptoru a léčivo pro léčbu zánětlivé choroby s jeho obsahem |
JP4738603B2 (ja) * | 2000-11-06 | 2011-08-03 | ライオン株式会社 | 歯ブラシ |
IL180679A0 (en) * | 2000-10-27 | 2009-02-11 | Pfizer Prod Inc | Process for the preparation of non-steroidal glucocorticoid receptor modulators |
EP1201649B1 (de) * | 2000-10-28 | 2006-05-31 | Pfizer Products Inc. | Modulatoren des Glucocorticoid-Rezeptors |
JP2007511501A (ja) * | 2003-11-13 | 2007-05-10 | ファイザー・プロダクツ・インク | グルココルチコイド受容体調節剤として有用なオクタヒドロフェナンスレンヒドラジド誘導体 |
CA2649894A1 (en) * | 2006-05-02 | 2007-11-15 | Corcept Therapeutics, Inc. | The use of a glucocorticoid receptor ii antagonist to treat depression in patients taking il-2 |
-
2008
- 2008-01-28 JP JP2009547779A patent/JP4579333B2/ja not_active Expired - Fee Related
- 2008-01-28 BR BRPI0807121-7A2A patent/BRPI0807121A2/pt not_active Application Discontinuation
- 2008-01-28 DE DE602008003405T patent/DE602008003405D1/de active Active
- 2008-01-28 AP AP2009004941A patent/AP2411A/xx active
- 2008-01-28 DK DK08702358.6T patent/DK2114888T3/da active
- 2008-01-28 EP EP08702358A patent/EP2114888B1/de active Active
- 2008-01-28 PL PL08702358T patent/PL2114888T3/pl unknown
- 2008-01-28 WO PCT/IB2008/000249 patent/WO2008093236A1/en active Application Filing
- 2008-01-28 EA EA200970662A patent/EA016001B1/ru not_active IP Right Cessation
- 2008-01-28 SI SI200830124T patent/SI2114888T1/sl unknown
- 2008-01-28 UZ UZ0900241A patent/UZ4378C/xx unknown
- 2008-01-28 MX MX2009008286A patent/MX2009008286A/es active IP Right Grant
- 2008-01-28 AT AT08702358T patent/ATE487700T1/de active
- 2008-01-28 AU AU2008211622A patent/AU2008211622B2/en not_active Ceased
- 2008-01-28 CA CA2676907A patent/CA2676907C/en not_active Expired - Fee Related
- 2008-01-28 NZ NZ578661A patent/NZ578661A/en not_active IP Right Cessation
-
2009
- 2009-07-23 IL IL200044A patent/IL200044A/en active IP Right Grant
-
2010
- 2010-02-12 HK HK10101644.6A patent/HK1135094A1/xx not_active IP Right Cessation
- 2010-12-27 HR HR20100726T patent/HRP20100726T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
BRPI0807121A2 (pt) | 2014-04-08 |
EA016001B1 (ru) | 2012-01-30 |
HK1135094A1 (en) | 2010-05-28 |
CA2676907C (en) | 2012-03-20 |
SI2114888T1 (sl) | 2011-02-28 |
NZ578661A (en) | 2010-12-24 |
AP2009004941A0 (en) | 2009-08-31 |
UZ4378C (en) | 2011-07-29 |
EP2114888B1 (de) | 2010-11-10 |
AU2008211622B2 (en) | 2012-04-19 |
AP2411A (en) | 2012-05-30 |
IL200044A (en) | 2015-06-30 |
EP2114888A1 (de) | 2009-11-11 |
CA2676907A1 (en) | 2008-08-07 |
HRP20100726T1 (hr) | 2011-04-30 |
MX2009008286A (es) | 2009-08-12 |
DE602008003405D1 (de) | 2010-12-23 |
WO2008093236A1 (en) | 2008-08-07 |
JP4579333B2 (ja) | 2010-11-10 |
EA200970662A1 (ru) | 2010-02-26 |
PL2114888T3 (pl) | 2011-04-29 |
AU2008211622A1 (en) | 2008-08-07 |
JP2010517991A (ja) | 2010-05-27 |
IL200044A0 (en) | 2010-04-15 |
DK2114888T3 (da) | 2011-01-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE518872T1 (de) | Trizyklische verbindungen und deren verwendung als glucocorticoidrezeptormodulatoren | |
ATE487700T1 (de) | Trizyklische verbindungen und deren verwendung als glucocorticoidrezeptormodulatoren | |
ATE473229T1 (de) | Tricyclische verbindungen und deren verwendung als mglur1-antagonisten | |
ATE537157T1 (de) | Substituierte phenoxy-n-alkylierte thiazoledindione als östrogenassoziierte rezeptor-alpha-modulatoren | |
DE602005023639D1 (de) | Chinuclidinderivate und deren verwendung als muscarin-m3-rezeptor-antagonisten | |
DE112008002275A5 (de) | Scheinwerferlampe und deren Verwendung | |
BRPI0918949A2 (pt) | moduladores de receptores de 5-ht2a e piperazina d3 | |
ATE538091T1 (de) | Tetrahydrocyclopentaäbüindolverbindungen als androgenrezeptormodulatoren | |
ATE489389T1 (de) | 2 -heteroaryl- pyrrolo ä3, 4-cüpyrrol- derivate und deren verwendung als scd inhibitoren | |
DE602007012308D1 (de) | Bicyclische pyrimidinone und deren verwendung | |
DE112009000115A5 (de) | Polyolefinfolie und Verwendung derselben | |
DE602007006540D1 (de) | Cyclopropancarboxylate und deren verwendung als pestizide | |
EP2314588A4 (de) | Verbindungen östrogenassoziierter rezeptormodulatoren und ihre verwendung | |
ATE512137T1 (de) | Benzoylpiperidinderivate als doppelmodulatoren des 5-ht2a- und des d3-rezeptors | |
DE602006005138D1 (de) | Nichtsteroide glucocorticoid-rezeptormodulatoren | |
DE602006007976D1 (de) | Benzimidazolderivate und deren verwendung zur modulation des gabaa-rezeptorkomplexes | |
BRPI0916574A2 (pt) | derivados de diazepano e piperazina moduladores de receptores de quiomiocinas | |
DE112009004836A5 (de) | Ecdyson-derivate und deren verwendung | |
DK2066677T3 (da) | Pyridooxazepinprogesteronreceptormodulatorer | |
ATE421516T1 (de) | Als modulatoren des glucocorticoidrezeptors geeignete nichtsteroidale verbindungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 2114888 Country of ref document: EP |